Coronavirus infection, caused primarily by SARS-CoV-2, presents with respiratory symptoms ranging from mild upper-airway congestion to severe pneumonia and acute respiratory distress syndrome. This category examines antiviral therapies, monoclonal antibody interventions, supportive oxygen management, and post-acute sequelae treatment. Articles address vaccination efficacy, isolation protocols, diagnostic testing accuracy, and risk stratification for immunocompromised populations. All content reflects peer-reviewed clinical data and aligns with current infectious disease guidelines to support informed patient decision-making and broader public health awareness.